Next Article in Journal
Pharmaceutical Approach to Develop Novel Photosensitizer Nanoformulation: An Example of Design and Characterization Rationale of Chlorophyll α Derivative
Previous Article in Journal
Correction: Yadav et al. PLGA-Quercetin Nano-Formulation Inhibits Cancer Progression via Mitochondrial Dependent Caspase-3,7 and Independent FoxO1 Activation with Concomitant PI3K/AKT Suppression. Pharmaceutics 2022, 14, 1326
 
 
Article

Article Versions Notes

Pharmaceutics 2024, 16(1), 125; https://doi.org/10.3390/pharmaceutics16010125
Action Date Notes Link
article xml file uploaded 18 January 2024 12:08 CET Original file -
article xml uploaded. 18 January 2024 12:08 CET Update -
article pdf uploaded. 18 January 2024 12:08 CET Version of Record https://www.mdpi.com/1999-4923/16/1/125/pdf-vor
article supplementary file uploaded. 18 January 2024 12:08 CET - https://www.mdpi.com/1999-4923/16/1/125#supplementary
article html file updated 18 January 2024 12:10 CET Original file -
article xml file uploaded 19 January 2024 03:13 CET Update -
article xml uploaded. 19 January 2024 03:13 CET Update https://www.mdpi.com/1999-4923/16/1/125/xml
article pdf uploaded. 19 January 2024 03:13 CET Updated version of record https://www.mdpi.com/1999-4923/16/1/125/pdf
article html file updated 19 January 2024 03:15 CET Update https://www.mdpi.com/1999-4923/16/1/125/html
Back to TopTop